$TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Insider Trading Week 10/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD in week 10/2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14 2019 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Option Exercise | M | 0.00 | 2,444 | 0 | 0 | |
| Mar 14 2019 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Sell | S | 15.82 | 2,444 | 38,664 | 2,974 | 5.4 K to 3 K (-45.11 %) |
| Mar 14 2019 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Buy | M | 0.00 | 2,444 | 0 | 5,418 | 3 K to 5.4 K (+82.18 %) |
| Mar 14 2019 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Option Exercise | M | 0.00 | 738 | 0 | 0 | |
| Mar 14 2019 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Sell | S | 15.67 | 738 | 11,568 | 1,388 | 2.1 K to 1.4 K (-34.71 %) |
| Mar 14 2019 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Buy | M | 0.00 | 738 | 0 | 2,126 | 1.4 K to 2.1 K (+53.17 %) |
| Mar 14 2019 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, Growth Markets ... | Option Exercise | M | 0.00 | 883 | 0 | 0 | |
| Mar 14 2019 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, Growth Markets ... | Sell | S | 15.69 | 325 | 5,099 | 8,450 | 8.8 K to 8.5 K (-3.70 %) |
| Mar 14 2019 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, Growth Markets ... | Buy | M | 0.00 | 883 | 0 | 8,775 | 7.9 K to 8.8 K (+11.19 %) |
| Mar 14 2019 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Option Exercise | M | 0.00 | 953 | 0 | 0 | |
| Mar 14 2019 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Sell | S | 15.67 | 953 | 14,938 | 0 | 953 to 0 (-100.00 %) |
| Mar 14 2019 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Buy | M | 0.00 | 953 | 0 | 953 | 0 to 953 |
| Mar 14 2019 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Option Exercise | M | 0.00 | 1,191 | 0 | 0 | |
| Mar 14 2019 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Sell | S | 15.67 | 647 | 10,142 | 8,602 | 9.2 K to 8.6 K (-7.00 %) |
| Mar 14 2019 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Buy | M | 0.00 | 1,191 | 0 | 9,249 | 8.1 K to 9.2 K (+14.78 %) |
| Mar 14 2019 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Option Exercise | M | 0.00 | 715 | 0 | 0 | |
| Mar 14 2019 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Sell | S | 15.69 | 715 | 11,218 | 0 | 715 to 0 (-100.00 %) |
| Mar 14 2019 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Buy | M | 0.00 | 715 | 0 | 715 | 0 to 715 |